Statin treatment and new-onset diabetes: a review of proposed mechanisms.
about
Risk of new-onset diabetes associated with statin useNonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB CouncilModulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by StatinsAssociation between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.Statins and New-Onset Diabetes Mellitus: LDL Receptor May Provide a Key Link.Evaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: a pilot prospective clinical trialStatin use and risk of diabetes mellitus.PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9.Caveolins in cardioprotection - translatability and mechanismsStatin Safety in Chinese: A Population-Based Study of Older AdultsSimvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanismStatin-activated nuclear receptor PXR promotes SGK2 dephosphorylation by scaffolding PP2C to induce hepatic gluconeogenesis.Rho-GTPase and Atherosclerosis: Pleiotropic Effects of StatinsRosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.Effect of Three Statins on Glucose Uptake of Cardiomyocytes and its MechanismDo statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies.Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.The Different Effects of Atorvastatin and Pravastatin on Cell Death and PARP Activity in Pancreatic NIT-1 Cells.High-density lipoprotein, beta cells, and diabetes .Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction.New onset diabetes mellitus induced by statins: current evidence.Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism.Exercise training prevents skeletal muscle plasma membrane cholesterol accumulation, cortical actin filament loss, and insulin resistance in C57BL/6J mice fed a western-style high-fat diet.Cardiovascular pleiotropic effects of statins and new onset diabetes: is there a common link: do we need to evaluate the role of KATP channels?Cardiovascular disease prevention strategies for type 2 diabetes mellitus.Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy.Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress.Involvement of peroxisome proliferator activated receptor-γ in the anti-inflammatory effects of atorvastatin in oxygen-glucose deprivation/reperfusion-stimulated RAW264.7 murine macrophages.Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium functionPharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects.Methylglyoxal attenuates insulin signaling and downregulates the enzymes involved in cholesterol biosynthesis.Statin therapy exacerbates alcohol-induced constriction of cerebral arteries via modulation of ethanol-induced BK channel inhibition in vascular smooth muscle.Unexplained reciprocal regulation of diabetes and lipoproteins.Pharmacometabolomic signature links simvastatin therapy and insulin resistance.Calcium Ion Channels: Roles in Infection and Sepsis Mechanisms of Calcium Channel Blocker Benefits in Immunocompromised Patients at Risk for Infection
P2860
Q26771800-EB8AFABF-8AFC-4449-9C4C-432C90B38EA8Q28084156-9003A01B-9E0E-4CBC-82E0-9263586147B5Q28551738-1712C828-4F92-4C69-BBB8-3353B0624075Q30241977-45B338C4-8E60-4362-82FD-D100F515B7CDQ33790331-262A8838-F472-42AB-A3DE-B0EFF8672394Q33965084-19FFD3DD-6249-400A-B1EA-7E9257DD9B27Q35179254-5C8C596B-A884-4EDA-A7A2-B4D3DDA69A97Q35262593-5C2288B3-88D9-4432-957B-E26F4AC5938DQ35286413-F6999CC3-79E4-486F-9ECB-7BEB43140644Q35949456-7CE1C22C-D1F9-4BE9-802A-453D7FF996CDQ36034049-6ADBFF29-975E-4FF0-9473-4AD1975C8C1EQ36099236-458FA563-0F6C-4FC4-979D-761FB08ADB8DQ36168823-DD0174E5-A942-412C-90CB-2B6ECCA29D96Q36187629-4A6C5608-8312-4927-ADE7-C5A619C1D7DEQ37175109-71D00379-7DEE-4BD7-982B-E18AC112DAA6Q37359219-2A844E92-6494-4928-B741-7533B82554EAQ37367952-9F2F436D-5B3D-49E5-B228-781AAFA108E5Q37433115-98DB7453-0B63-4103-BA49-EFBC3729C34EQ37492634-D0F78054-D783-4DB0-BE0B-FB33BA88B843Q38218039-EE96850B-DA7D-48EB-8EFF-0844BED0ED2DQ38253151-A72041D1-D67A-426A-974A-07F2105F8E99Q38432738-F185FF96-D972-4681-90EF-235AC3151701Q38600327-1354299D-EC20-45A5-A55E-7C79F920B65EQ38623182-36859499-831A-45BB-81C1-006D9304CF4FQ39344414-AF05ED1A-F948-49E6-AFB0-3AAE95CE064FQ39420208-3D85A76C-98B1-448A-AAB9-826D3C450592Q39918625-31C9E062-5389-4930-A194-312F37BD2910Q40735838-FBDFC252-53BE-4330-A71E-52A268529ACAQ41336155-FEA26DDD-3870-4537-8F62-1D451E2905B3Q41494768-D6902084-753B-47F1-892A-8A0F57434D8CQ41703537-68EEE366-BD59-4217-A433-567F510C28ABQ41778664-24AF86DC-8C63-4D96-BE96-F0880B181308Q42128953-F1A1DF29-5F33-4C40-92F8-26C79193BFD9Q47137239-B22A73FB-48C9-4E6C-9A64-86B62D4A872AQ47779685-8B0240B8-A6BD-4478-BC1B-A209F35091CEQ47865448-6284E9CA-0E72-4BA9-BF45-6FC8D8632998Q53690107-266538E7-436C-482D-87BF-C5476F85DE9EQ53755580-2D324C19-940C-4DD7-B4EC-F529526DF362Q58725666-8976B5FC-2F3B-45B7-A481-DF9836EC38DB
P2860
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@ast
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@en
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@nl
type
label
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@ast
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@en
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@nl
prefLabel
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@ast
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@en
Statin treatment and new-onset diabetes: a review of proposed mechanisms.
@nl
P2093
P1433
P1476
Statin treatment and new-onset diabetes: a review of proposed mechanisms
@en
P2093
Christos S Mantzoros
Marilyne Brault
Stella S Daskalopoulou
Yessica-Haydee Gomez
P304
P356
10.1016/J.METABOL.2014.02.014
P50
P577
2014-02-25T00:00:00Z